Rxcurve
HCPCS J9260 · per 50 MG

Inj methotrexate sodium 50mg

Products billed under this code include Methotrexate Sodium.

Payment limit per 50 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9260

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Methotrexate Sodium Hikma Pharmaceuticals USA Inc. 00143-9367-01 20 $58.18
Methotrexate Sodium Hikma Pharmaceuticals USA Inc. 00143-9519-10 10 $29.09
Methotrexate Sodium Hikma Pharmaceuticals USA Inc. 00143-9830-01 20 $58.18
Methotrexate Sodium Teva Parenteral Medicines, Inc. 00703-3671-01 1 $2.909
Methotrexate Sodium Teva Parenteral Medicines, Inc. 00703-3675-01 5 $14.545
Methotrexate Sodium Teva Parenteral Medicines, Inc. 00703-3678-01 20 $58.18
Methotrexate Sodium Teva Parenteral Medicines, Inc. 00703-3678-81 20 $58.18
Methotrexate Sodium ACCORD HEALTHCARE INC 16729-0277-03 5 $14.545
Methotrexate Sodium Accord Healthcare Inc 16729-0277-30 1 $2.909
Methotrexate Sodium Accord Healthcare Inc 16729-0277-35 20 $58.18
Show all 18 products
ProductLabelerNDCUnits / pkgLimit / pkg
Methotrexate Sodium Pfizer Inc 61703-0124-40 20 $58.18
Methotrexate Sodium Pfizer Inc 61703-0161-05 5 $14.545
Methotrexate Sodium Pfizer Inc 61703-0350-10 5 $14.545
Methotrexate Sodium Pfizer Inc 61703-0350-38 5 $14.545
Methotrexate Sodium Pfizer Inc 61703-0408-25 20 $58.18
Methotrexate Sodium Pfizer Inc 61703-0408-41 20 $58.18
Methotrexate Sodium FreseniUS Kabi USA, LLC 63323-0122-50 20 $58.18
Methotrexate Sodium FreseniUS Kabi USA, LLC 63323-0123-10 5 $14.545

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $2.909 −$0.032 50 MG Inj methotrexate sodium 50mg v1, posted September 17, 2026
3Q26 $2.941 +$0.264 50 MG Inj methotrexate sodium 50mg v1, posted September 15, 2026
2Q26 $2.677 +$0.098 50 MG Inj methotrexate sodium 50mg v1, posted September 15, 2026
1Q26 $2.579 −$0.237 50 MG Inj methotrexate sodium 50mg v1, posted September 15, 2026
4Q25 $2.816 +$0.553 50 MG Inj methotrexate sodium 50mg v1, posted September 8, 2026
3Q25 $2.263 −$0.321 50 MG Inj methotrexate sodium 50mg v1, posted March 10, 2026
2Q25 $2.584 −$0.789 50 MG Inj methotrexate sodium 50mg v1, posted March 10, 2026
1Q25 $3.373 +$0.65 50 MG Inj methotrexate sodium 50mg v1, posted December 19, 2025
4Q24 $2.723 +$0.142 50 MG Inj methotrexate sodium 50mg v1, posted June 11, 2025
3Q24 $2.581 +$0.009 50 MG Methotrexate sodium inj v1, posted June 11, 2025
2Q24 $2.572 −$0.461 50 MG Methotrexate sodium inj v1, posted March 11, 2025
1Q24 $3.033 +$0.708 50 MG Methotrexate sodium inj v1, posted December 19, 2024
4Q23 $2.325 −$0.385 50 MG Methotrexate sodium inj v1, posted October 10, 2024
3Q23 $2.71 +$0.263 50 MG Methotrexate sodium inj v1, posted June 5, 2024
2Q23 $2.447 +$0.256 50 MG Methotrexate sodium inj v1, posted February 23, 2024
1Q23 $2.191 −$0.43 50 MG Methotrexate sodium inj v1, posted December 6, 2023
4Q22 $2.621 +$0.647 50 MG Methotrexate sodium inj v1, posted June 22, 2023
3Q22 $1.974 −$0.386 50 MG Methotrexate sodium inj v1, posted June 9, 2023
2Q22 $2.36 +$0.289 50 MG Methotrexate sodium inj v1, posted December 14, 2022
1Q22 $2.071 −$0.086 50 MG Methotrexate sodium inj v1, posted June 8, 2022
4Q21 $2.157 −$0.076 50 MG Methotrexate sodium inj v1, posted June 2, 2022
3Q21 $2.233 +$0.118 50 MG Methotrexate sodium inj v1, posted June 2, 2022
2Q21 $2.115 +$0.012 50 MG Methotrexate sodium inj v1, posted March 1, 2022
1Q21 $2.103 – 50 MG Methotrexate sodium inj v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files